Introduction
The relationship between disruptions in the intestinal microbiome, psychological well-being, and modern lifestyle factors in individuals with prevalent non-communicable diseases, such as atherosclerosis, has been partially elucidated but remains inadequately investigated. This raises the inquiry into the feasibility of diagnosing, preventing, and treating atherosclerosis through the measurement and adjustment of disease markers associated with intestinal microbiome, psychological state, and lifestyle indicators.
Aims & Methods
This study aims to broaden the spectrum of these markers to a degree adequate for establishing models to diagnose atherosclerosis within the alternative categories of "no atherosclerosis," "asymptomatic atherosclerosis," and "symptomatic atherosclerosis," as well as by the level of associated health risks (non-significant, significant, and high). Our cohort study data were employed to fulfill this goal.
Results
We identified microbial markers from 955 gut microbiome species and other markers from 52 indicators of psychological state and lifestyle among participants. Marker properties were assessed based on their ability to distinguish between "no atherosclerosis," "asymptomatic atherosclerosis," and "symptomatic atherosclerosis" groups, as well as "not significant risk," "significant risk," and "high risk" groups. We measured their correlation with each participant's group membership using the p-level parameter to prioritize markers, resulting in a rating for each. Eleven microbial species (including Oxalobacter aliiformigenes, Lactobacillus acidophilus, and Bifidobacterium longum) and six other indicators (including "feeling of slowness" and "duration of physical activity") showed the highest scores. Cluster-type models based on these markers accurately predict group membership, with predictive accuracies ranging from 93.7% to 97.1%. This study provides novel insights into atherosclerosis-associated markers, laying a foundation for future research in this field.
Conclusion
The inclusion of microbial, psychological state, and lifestyle indicators has significantly enhanced the existing markers for atherosclerosis. These new markers have facilitated the development of models that, for the first time, enable the diagnosis of atherosclerosis within the categories of "no atherosclerosis," "asymptomatic atherosclerosis," and "symptomatic atherosclerosis," as well as by the associated health risks (non-significant, significant, and high). In addition to microbial markers, these models also incorporate an individual's psychological state and lifestyle indicators.
References
- Meleshko T. V., Pallah O. V., Rukavchuk R. O., Yusko L. S., & Boyko N. V. (2020). Edible Fruits Extracts Affect Intestinal Microbiota Isolated from Patients with Noncommunicable Diseases Associated With Chronic Inflammation. Biotechnologia Acta, 13 (5), 87-100.
- Toth, S., Boyko, N., & Sihotsky, V. (2021). Hypothesis of “stroke-stop” formula: a tool for risk index determination in development of acute cerebrovascular disease in asymptomatic individuals with carotid stenosis.
- Bubnov, R. V., Spivak, M. Y., Lazarenko, L. M., Bomba, A., & Boyko, N. V. (2015). Probiotics and immunity: provisional role for personalized diets and disease prevention. EPMA Journal, 6, 1-11.
- Kopolovets, I., Berek, P., Stefanic, P., Lotnyk, D., Mucha, R., Hertelyova, Z., ... & Sihotsky, V. (2020). Relevance of Lp-PLA2 blood concentration for morphological structure of atherosclerotic plaque: a shift from reactive to predictive, preventive and personalized medicine to predict stroke in patients with asymptomatic internal carotid artery stenosis.